Literature DB >> 9027319

Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta).

B Contempre1, O Le Moine, J E Dumont, J F Denef, M C Many.   

Abstract

Free radical damage and fibrosis caused by selenium deficiency are thought to be involved in the pathogenesis of myxoedematous cretinism. So far, no pathway explains the link between selenium deficiency and tissue fibrosis. Pharmacological doses of iodine induce necrosis in iodine-deficient thyroids. Necrosis is much increased if the glands are also selenium-deficient, which then evolve to fibrosis. This rat model was reproduced to explore the role of selenium deficiency in defective tissue repair. At first, proliferation indexes of epithelial cells and fibroblasts were comparable between selenium-deficient and control groups. Then, in selenium-deficient thyroids the inflammatory reaction was more marked being mainly composed of macrophages. The proliferation index of the epithelial cells decreased, while that of the fibroblasts increased. These thyroids evolved to fibrosis. TGF-beta immunostaining was prominent in the macrophages of selenium-deficient rats. Anti TGF-beta antibodies restored the proliferation indexes, and blocked the evolution to fibrosis. In selenium deficiency, an active fibrotic process occurs in the thyroid, in which the inflammatory reaction and an excess of TGF-beta play a key role.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027319     DOI: 10.1016/s0303-7207(96)03921-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

3.  Selenium: its role as antioxidant in human health.

Authors:  Ujang Tinggi
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

Review 4.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

Review 5.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

6.  Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

Authors:  F Depoortere; I Pirson; J Bartek; J E Dumont; P P Roger
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

7.  [Selenoproteins in bone, gastrointestinal tract and thyroid gland of the human].

Authors:  F Jakob; H Mörk; N Schütze; I Dreher; C Schmutzler; B Lex; J Köhrle
Journal:  Med Klin (Munich)       Date:  1997-09-15

Review 8.  Selenium: an element for life.

Authors:  Leonidas H Duntas; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-12-18       Impact factor: 3.633

9.  Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts.

Authors:  Rosaria M Ruggeri; Angela D'Ascola; Teresa M Vicchio; Salvatore Campo; Fiorenza Gianì; Salvatore Giovinazzo; Francesco Frasca; Salvatore Cannavò; Alfredo Campennì; Francesco Trimarchi
Journal:  Endocrine       Date:  2019-12-30       Impact factor: 3.633

Review 10.  Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.

Authors:  Natalie Sampson; Peter Berger; Christoph Zenzmaier
Journal:  Oxid Med Cell Longev       Date:  2012-10-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.